Neogen Corporation (NEOG)Healthcare | Medical Devices | Lansing, United States | NasdaqGS
9.51 USD
+0.27
(2.922%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 9.50 -0.01 (-0.011%) ⇩ (April 17, 2026, 5:48 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:15 p.m. EDT
NEOG is currently trading near its 52-week low, with a negative profit margin and a high debt-to-equity ratio. The recent price movements show some volatility, but the overall trend is mixed. The options activity indicates a lack of consensus among traders, which could mean that the stock is still in a phase of uncertainty. Given the negative fundamentals and lack of dividend history, it's not advisable to invest for the long term. Short-term traders should be cautious, as the forecasting model suggests minimal price movement in the next 45 days. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.072272 |
| MSTL | 0.076399 |
| AutoTheta | 0.178554 |
| AutoARIMA | 0.300414 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 54% |
| H-stat | 2.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.164 |
| Excess Kurtosis | -1.39 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 37.819 |
| Revenue per Share | 4.006 |
| Market Cap | 2,070,070,656 |
| Forward P/E | 32.42 |
| Beta | 1.97 |
| Profit Margins | -69.94% |
| Website | https://www.neogen.com |
As of April 11, 2026, 3:15 p.m. EDT: Options speculators are showing mixed signals. There is significant put and call activity, particularly around the $10.0 strike price, indicating some uncertainty. The high open interest in puts suggests potential bearish sentiment, while the presence of call options might indicate bullish expectations. However, the volatility and the lack of clear direction in the options data suggest a cautious approach.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0277185 |
| Address1 | 620 Lesher Place |
| All Time High | 48.85 |
| All Time Low | 0.122253 |
| Ask | 9.67 |
| Ask Size | 34 |
| Audit Risk | 10 |
| Average Analyst Rating | 2.3 - Buy |
| Average Daily Volume10 Day | 3,317,980 |
| Average Daily Volume3 Month | 2,938,369 |
| Average Volume | 2,938,369 |
| Average Volume10Days | 3,317,980 |
| Beta | 1.967 |
| Bid | 9.35 |
| Bid Size | 34 |
| Board Risk | 3 |
| Book Value | 9.659 |
| City | Lansing |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.51 |
| Current Ratio | 3.918 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 9.7 |
| Day Low | 9.37 |
| Debt To Equity | 37.819 |
| Display Name | Neogen |
| Earnings Call Timestamp End | 1,775,736,000 |
| Earnings Call Timestamp Start | 1,775,736,000 |
| Earnings Timestamp | 1,775,737,800 |
| Earnings Timestamp End | 1,775,737,800 |
| Earnings Timestamp Start | 1,775,737,800 |
| Ebitda | 81,262,000 |
| Ebitda Margins | 0.093339995 |
| Enterprise To Ebitda | 33.291 |
| Enterprise To Revenue | 3.108 |
| Enterprise Value | 2,705,270,528 |
| Eps Current Year | 0.37 |
| Eps Forward | 0.29333 |
| Eps Trailing Twelve Months | -2.8 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 9.9844 |
| Fifty Day Average Change | -0.47439957 |
| Fifty Day Average Change Percent | -0.04751408 |
| Fifty Two Week Change Percent | 102.77185 |
| Fifty Two Week High | 11.43 |
| Fifty Two Week High Change | -1.9200001 |
| Fifty Two Week High Change Percent | -0.167979 |
| Fifty Two Week Low | 4.46 |
| Fifty Two Week Low Change | 5.05 |
| Fifty Two Week Low Change Percent | 1.132287 |
| Fifty Two Week Range | 4.46 - 11.43 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 619,882,200,000 |
| Float Shares | 216,506,314 |
| Forward Eps | 0.29333 |
| Forward P E | 32.420822 |
| Free Cashflow | 19,474,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 2,974 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.45209 |
| Gross Profits | 393,576,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.009380001 |
| Held Percent Institutions | 1.06919 |
| Implied Shares Outstanding | 217,673,041 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.neogen.com/Corporate/invest.html |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,748,649,600 |
| Last Split Date | 1,623,024,000 |
| Last Split Factor | 2:1 |
| Long Business Summary | Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. |
| Long Name | Neogen Corporation |
| Market | us_market |
| Market Cap | 2,070,070,656 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_339683 |
| Most Recent Quarter | 1,772,236,800 |
| Net Income To Common | -608,844,032 |
| Next Fiscal Year End | 1,780,185,600 |
| Non Diluted Market Cap | 2,068,982,254 |
| Number Of Analyst Opinions | 3 |
| Open | 9.42 |
| Operating Cashflow | 69,444,000 |
| Operating Margins | -0.01563 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.66 |
| Phone | 517 372 9200 |
| Post Market Change | -0.010900497 |
| Post Market Change Percent | -0.11462142 |
| Post Market Price | 9.4991 |
| Post Market Time | 1,776,462,488 |
| Previous Close | 9.24 |
| Price Eps Current Year | 25.702703 |
| Price Hint | 2 |
| Price To Book | 0.98457396 |
| Price To Sales Trailing12 Months | 2.3778582 |
| Profit Margins | -0.69936997 |
| Quick Ratio | 1.972 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.25 |
| Region | US |
| Regular Market Change | 0.27 |
| Regular Market Change Percent | 2.92208 |
| Regular Market Day High | 9.7 |
| Regular Market Day Low | 9.37 |
| Regular Market Day Range | 9.37 - 9.7 |
| Regular Market Open | 9.42 |
| Regular Market Previous Close | 9.24 |
| Regular Market Price | 9.51 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 1,773,929 |
| Return On Assets | -0.00607 |
| Return On Equity | -0.25566998 |
| Revenue Growth | -0.044 |
| Revenue Per Share | 4.006 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 217,673,041 |
| Shares Percent Shares Out | 0.0463 |
| Shares Short | 10,069,503 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 9,906,307 |
| Short Name | Neogen Corporation |
| Short Percent Of Float | 0.0618 |
| Short Ratio | 4.09 |
| Source Interval | 15 |
| State | MI |
| Symbol | NEOG |
| Target High Price | 13.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 159,900,000 |
| Total Cash Per Share | 0.735 |
| Total Debt | 795,100,032 |
| Total Revenue | 870,561,024 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.27175 |
| Two Hundred Day Average Change | 2.2382503 |
| Two Hundred Day Average Change Percent | 0.30780077 |
| Type Disp | Equity |
| Volume | 1,773,929 |
| Website | https://www.neogen.com |
| Zip | 48,912-1595 |